As the EU transitions to its long-awaited new Clinical Trial Regulation (CTR), researchers, site managers and trial coordinators in the U.S. and other countries should keep an eye on how the regulation rolls out in early 2022 and its impact on data-sharing, transparency and acceleration of trial startup, even on trials conducted in the U.S.